Philip Prince

Philip Prince has over 20 years of experience in various roles in the pharmaceutical industry. Philip is currently working at Agios Pharmaceuticals as the Vice President, PK Activator Portfolio Lead. Prior to this, they held the position of Vice President of Marketing at Agios Pharmaceuticals. From 2018 to 2021, they served as the Sr. Director of Rare Genetic Disease Marketing, where they developed and executed the Rare Disease Commercial Strategy. Philip also has experience at Takeda Oncology, where they held positions such as Director of Global Marketing for ADCETRIS and Director of Proteasome Inhibitor Franchise Marketing. Before Takeda Oncology, Philip worked at Merck as an Analyst/Associate Manager in Global Market Research, Oncology. Philip started their career at The Dow Chemical Company as a Process Engineer.

Philip Prince completed their Bachelor of Science (BS) degree in Chemical Engineering from Missouri University of Science and Technology in the years 1997 to 2000. Philip then pursued further education and obtained a Master of Business Administration (MBA) degree with a specialization in Marketing from the University of Michigan - Stephen M. Ross School of Business from 2005 to 2007.